Article

Early diastolic mitral annular velocity and color M-mode flow propagation velocity in the evaluation of left ventricular diastolic function in patients with Fabry disease.

Second Department of Internal Medicine, First School of Medicine, Charles University, U nemocnice 2, 128 08 Prague 2, Czech Republic, .
Heart and Vessels (impact factor: 2.05). 01/2006; 21(1):13-9. DOI:10.1007/s00380-005-0852-6
Source: PubMed

ABSTRACT Fabry disease is an X-linked genetic disorder characterized by progressive intracellular accumulation of neutral glycosphingolipids. Cardiac involvement is frequent and left ventricular (LV) diastolic dysfunction is present in most of the affected subjects. Pulsed-wave tissue Doppler echocardiography (PW-TDE) and color M-mode are new Doppler methods for LV diastolic function evaluation. Their role in the assessment of Fabry disease-related cardiomyopathy remains to be established. In this study we aimed to determine the utility of PW-TDE and color M-mode-derived parameters in the assessment of LV diastolic function in patients with Fabry disease. Eighty-one echocardiographic examinations performed in 35 patients affected by Fabry disease were retrospectively analyzed. Early diastolic lateral mitral annular velocity (E(m)) determined by PW-TDE and color M-mode flow propagation velocity (V(p)) were measured and compared to LV filling patterns obtained using standard Doppler indexes. The receiver operating characteristics (ROC) curves method was used to determine the summary measure of relative accuracy for E(m) and V(p). A comparison of ROC curves showed a significant difference for areas under the curve in favor of E(m) (P < 0.001). Pseudonormal filling pattern, higher LV mass index, higher relative wall thickness, larger left atrial diameter, and older age were more frequent (all P < 0.001) in patients with incorrect diagnosis of normal LV diastolic function based on the measurement of V(p). E(m) appears to be superior to V(p) in the assessment of LV diastolic function in patients with Fabry disease. V(p) fails to detect abnormal LV diastolic function in subjects with pronounced concentric LV remodeling and pseudonormal filling pattern.

0 0
 · 
0 Bookmarks
 · 
22 Views
  • Article: Narrative review: Fabry disease.
    [show abstract] [hide abstract]
    ABSTRACT: Fabry disease is an X-linked, hereditary, lysosomal storage disease caused by deficiency of the enzyme alpha-galactosidase A, which results in the accumulation of the neutral glycosphingolipid globotriaosylceramide (Gb3) in the walls of small blood vessels, nerves, dorsal root ganglia, renal glomerular and tubular epithelial cells, and cardiomyocytes. It is a complex, multisystem disorder that is characterized clinically by chronic pain and acroparesthesia, gastrointestinal disturbances, characteristic skin lesions (angiokeratomata), progressive renal impairment, cardiomyopathy, and stroke. Enzyme replacement therapy (ERT) with intravenous infusions of recombinant human alpha-galactosidase A consistently decreases Gb3 levels in plasma and clears lysosomal inclusions from vascular endothelial cells. The effects of ERT on other tissues are not as obvious, suggesting that treatment must be initiated early in the course of the disease to be optimally effective or that some complications of the disease are not responsive to enzymes delivered intravenously.
    Annals of internal medicine 04/2007; 146(6):425-33. · 16.73 Impact Factor

Keywords

35 patients
 
abnormal LV diastolic function
 
affected subjects
 
Cardiac involvement
 
color M-mode
 
color M-mode flow propagation velocity
 
color M-mode-derived parameters
 
diastolic lateral mitral annular velocity
 
Fabry disease-related cardiomyopathy
 
higher LV mass index
 
higher relative wall thickness
 
incorrect diagnosis
 
LV diastolic function
 
LV diastolic function evaluation
 
neutral glycosphingolipids
 
normal LV diastolic function
 
progressive intracellular accumulation
 
Pulsed-wave tissue Doppler echocardiography
 
ROC curves
 
X-linked genetic disorder